425: Strive & Semler Scientific Merger: Risks & Outlook

Strive, Inc. and Semler Scientific, Inc. announce a proposed business combination, outlining associated risks and future steps.

Summary

• A communication from Strive's Chief Risk Officer, Jeff Walton, was posted on X.com on September 22, 2025, regarding the proposed business combination with Semler Scientific.
• The filing serves as a cautionary statement concerning forward-looking statements related to the merger, highlighting inherent risks and uncertainties.
• Strive intends to file a Registration Statement on Form S-4 with the SEC, which will include an Information Statement/Proxy Statement/Prospectus.
• Semler Scientific stockholders will receive the Information Statement/Proxy Statement/Prospectus to seek their approval of the proposed transaction.
• Strive, Semler Scientific, and certain directors/executive officers may be deemed participants in the solicitation of proxies.
• This communication is not an offer to sell or solicit securities or votes, and no offer of securities will be made except via a prospectus or an exemption.

Sentiment

Score: 5

Explanation: The filing is primarily a cautionary statement about a proposed merger, detailing numerous risks and uncertainties. While it mentions potential benefits, the emphasis is heavily on the 'forward-looking statements' disclaimer and associated risks, leading to a neutral-to-cautious sentiment.

Positives

• The proposed transaction aims for strategic and financial benefits for the combined company.
• Anticipated cost savings and strategic gains are expected to be realized from the business combination.

Negatives

• Integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The proposed transaction may be more expensive or take longer to complete than anticipated due to unexpected factors or events.
• Management's attention may be diverted from ongoing business operations and opportunities.
• Potential adverse reactions from customers or changes to business or employee relationships could arise from the announcement or completion of the transaction.
• Changes in Strive's or Semler Scientific's share price before closing could negatively impact the transaction or shareholder value.

Risks

• The occurrence of any event, change, or circumstance that could give rise to the right of either Strive or Semler Scientific to terminate the merger agreement.
• The possibility that the proposed transaction does not close when expected or at all because conditions to closing are not received or satisfied on a timely basis or at all.
• The outcome of any legal proceedings that may be instituted against Strive, Semler Scientific, or the combined company.
• The possibility that anticipated benefits of the proposed transaction, including cost savings and strategic gains, are not realized when expected or at all.
• Risks associated with changes in, or problems arising from, implementation of Bitcoin treasury strategies and other digital assets.
• General economic and market conditions, interest and exchange rates, monetary policy, and laws and regulations and their enforcement could impact anticipated benefits.
• The possibility that the integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The possibility that the proposed transaction may be more expensive or take longer to complete than anticipated.
• Diversion of management's attention from ongoing business operations and opportunities.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.
• Potential adverse reactions of Strive's or Semler Scientific's customers or changes to business or employee relationships.
• Changes in Strive's or Semler Scientific's share price before closing.
• Other factors that may affect future results of Strive, Semler Scientific, or the combined company, including unknown or unpredictable factors.

Future Outlook

The proposed transaction is expected to have a positive impact on the combined company's future financial performance, aiming for strategic and financial benefits. However, this outlook is subject to significant risks and uncertainties, including potential integration difficulties, market conditions, and regulatory changes.

Management Comments

• Jeff Walton, Chief Risk Officer of Strive, Inc., posted a communication on X.com on September 22, 2025, in connection with Strive's proposed business combination with Semler Scientific, Inc.

Industry Context

The filing highlights risks associated with 'Bitcoin treasury strategies and other digital assets,' indicating that the combined entity may engage in or be exposed to digital asset investments, aligning with a growing, albeit volatile, trend in corporate treasury management.

Legal Proceedings

• The outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company is identified as a risk factor.

Related Party Transactions

• Information about Semler Scientific's transactions with related persons will be set forth in its definitive proxy statement in connection with its 2025 Annual Meeting of Stockholders.

Stakeholder Impact

• Shareholders of Strive face potential dilution due to the issuance of additional Class A common stock.
• Shareholders of Semler Scientific will need to approve the proposed transaction.
• Customers of both companies may have adverse reactions or experience changes to business relationships.
• Employees of both companies may experience changes to their relationships or employment conditions.

Next Steps

• Strive intends to file a Registration Statement on Form S-4 with the SEC to register the Class A common stock to be issued.
• The Registration Statement will include an Information Statement of Strive, a proxy statement of Semler Scientific, and a prospectus of Strive.
• A definitive Information Statement/Proxy Statement/Prospectus will be sent to the stockholders of Semler Scientific to seek their approval of the proposed transaction.
• Investors and stockholders of Semler Scientific are urged to read the Registration Statement and Information Statement/Proxy Statement/Prospectus when they become available.

Key Dates

Keywords

Strive, Semler Scientific, Merger, Acquisition, Business Combination, SEC Filing, Form 425, Corporate Governance, Risk Management, Bitcoin, Digital Assets, Shareholder Approval